Published in Nature on May 23, 1991
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol (1994) 3.34
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (1995) 2.68
Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A (1994) 2.47
HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J (2003) 2.47
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J (1995) 2.41
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ Health Perspect (1993) 2.30
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol (2000) 2.23
Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21
Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas. Gut (2014) 2.19
The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun (2013) 2.17
Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A (1995) 2.11
Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A (1993) 2.06
Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol (1992) 2.04
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol (1997) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology (2011) 1.82
Hepatitis B virus-induced oncogenesis. World J Gastroenterol (2007) 1.82
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1997) 1.79
Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol (2002) 1.78
Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol (2003) 1.76
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A (2009) 1.74
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol (2000) 1.73
Viral hepatocarcinogenesis. Oncogene (2010) 1.73
The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci U S A (1995) 1.71
Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med (2000) 1.68
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol (1996) 1.65
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol (1995) 1.63
Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol (1996) 1.62
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A (1997) 1.60
Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol (2001) 1.59
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol (1999) 1.57
Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol (2012) 1.57
Retracted Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem (2009) 1.56
The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest (2002) 1.55
The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A (1997) 1.46
Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am J Pathol (2014) 1.44
The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol (2005) 1.43
Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J (1992) 1.43
Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A (2007) 1.41
Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin (2010) 1.40
RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol (1998) 1.39
Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) (2009) 1.37
Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol (1996) 1.35
Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol (1996) 1.35
Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J Gastroenterol (1999) 1.34
Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest (1996) 1.33
Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol (2011) 1.28
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest (2001) 1.27
Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol (1997) 1.25
pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J (1996) 1.24
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett (2010) 1.22
Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol (2005) 1.22
Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest (1994) 1.19
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci U S A (1996) 1.18
The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev (2001) 1.17
Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol (2008) 1.17
Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J (2003) 1.16
Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg (2006) 1.15
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. J Gastroenterol (2009) 1.13
Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol (2001) 1.11
Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology (2012) 1.10
Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol (2000) 1.08
Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame. J Virol (2001) 1.08
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res (1996) 1.07
Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol (2002) 1.06
Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS One (2011) 1.05
Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer (2011) 1.05
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci (2010) 1.05
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med (2014) 1.04
Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol (2014) 1.04
Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clin Vaccine Immunol (2011) 1.03
Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction. Proc Natl Acad Sci U S A (2012) 1.03
The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. J Virol (2010) 1.02
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology (2009) 1.01
Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr (1997) 1.00
Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer (2010) 1.00
Diverse modes of genomic alteration in hepatocellular carcinoma. Genome Biol (2014) 0.99
Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc Natl Acad Sci U S A (1992) 0.99
Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation. Autophagy (2013) 0.99
Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol (2003) 0.99
Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China. Int J Clin Exp Pathol (2013) 0.99
HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol Cancer (2011) 0.98
The hepatitis B virus X protein transactivates viral core gene expression in vivo. J Virol (1999) 0.98
Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol (2009) 0.98
Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) (2005) 0.98
COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J Gastroenterol (2008) 0.98
Mouse models in liver cancer research: a review of current literature. World J Gastroenterol (2008) 0.98
Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci U S A (1992) 0.96
Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim Biophys Acta (2011) 0.96
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A (1987) 4.72
Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science (1997) 4.62
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48
Localization of the ASV src gene product to the plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell (1979) 4.30
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res (1989) 4.29
The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science (1987) 4.01
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A (1996) 3.85
Identification of the SV40 agnogene product: a DNA binding protein. Nature (1981) 3.80
p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A (1981) 3.72
Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene (1998) 3.31
Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan. Lancet (2000) 3.20
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J Virol (1988) 3.03
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol (1997) 2.98
Complete nucleotide sequence and genetic organization of Aichi virus, a distinct member of the Picornaviridae associated with acute gastroenteritis in humans. J Virol (1998) 2.85
Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res (1995) 2.79
Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol (1999) 2.77
Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers. Nucleic Acids Res (1990) 2.76
Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms. Neurosurgery (1995) 2.71
Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63
Molecular clock of silent substitution: at least six-fold preponderance of silent changes in mitochondrial genes over those in nuclear genes. J Mol Evol (1982) 2.58
DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1995) 2.57
Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene (1984) 2.56
Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis (1999) 2.52
Unusual features in the nucleotide sequence of a cDNA clone derived from the common region of avian sarcoma virus messenger RNA. Proc Natl Acad Sci U S A (1980) 2.45
Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J Clin Microbiol (1991) 2.44
Charomids: cosmid vectors for efficient cloning and mapping of large or small restriction fragments. Proc Natl Acad Sci U S A (1986) 2.42
Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother (1996) 2.42
Angiotensin II antagonists for hypertension: are there differences in efficacy? Am J Hypertens (2000) 2.35
Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia. Science (2001) 2.29
Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol (1997) 2.25
Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science (1985) 2.23
Structure and gene organization in the transformed Hind III-G fragment of Ad12. Cell (1980) 2.22
Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science (1985) 2.22
Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion (2001) 2.16
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
Characterization of pseudotype VSV possessing HCV envelope proteins. Virology (2001) 2.15
Secretion of a transplantation-related antigen. Cell (1983) 2.12
A nonpolymorphic class I gene in the murine major histocompatibility complex. Cell (1984) 2.12
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A (1990) 2.12
Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis. Gene (1990) 2.12
Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science (1989) 2.08
The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol (1986) 2.08
Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science (1997) 2.06
A transgenic mouse model for human neurofibromatosis. Science (1987) 2.05
The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet (1995) 2.03
Transgenesis by adenovirus-mediated gene transfer into mouse zona-free eggs. Nat Biotechnol (1996) 2.03
Gene expression: chemical synthesis of E. coli ribosome binding sites and their use in directing the expression of mammalian proteins in bacteria. Nucleic Acids Res (1982) 2.01
Scanning of guanine-guanine mismatches in DNA by synthetic ligands using surface plasmon resonance. Nat Biotechnol (2001) 1.98
Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature (1989) 1.98
A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol (1994) 1.97
The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol (1990) 1.91
Expression of processed core protein of hepatitis C virus in mammalian cells. J Virol (1991) 1.91
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res (2001) 1.91
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 1.90
Intrafamilial transmission of hepatitis C virus. Lancet (1989) 1.90
Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol (1985) 1.88
Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem (1996) 1.85
Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest (1995) 1.85
Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol (1997) 1.82
Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet (1995) 1.80
Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke (1998) 1.79
Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg (1992) 1.77
Tissue-specific expression of an unusual H-2 (class I)-related gene. Proc Natl Acad Sci U S A (1982) 1.76
Identification of a transformation-specific protein induced by a Rous sarcoma virus. Cell (1978) 1.74
A common transformation-related protein in murine sarcomas and leukemias. Cold Spring Harb Symp Quant Biol (1980) 1.74
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology (1994) 1.74
Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG. Hum Gene Ther (1998) 1.72
Arteriovenous malformations in the basal ganglia and thalamus: management and results in 101 cases. J Neurosurg (1998) 1.72
Discrete regions of simian virus 40 large T antigen are required for nonspecific and viral origin-specific DNA binding. J Virol (1982) 1.71
Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol (1992) 1.68
Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol (1999) 1.63
Human error in medicine: promise and pitfalls, part 2. Ann Emerg Med (2000) 1.61
Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu Rev Immunol (1988) 1.60
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology (1999) 1.60
Simian virus 40-specific ribosome-binding proteins induced by a nondefective adenovirus 2-simian virus 40 hybrid. J Virol (1977) 1.59
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer (2012) 1.58
Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus. Proc Natl Acad Sci U S A (1984) 1.58
Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci U S A (1985) 1.57
Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem (2000) 1.57
Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol (1982) 1.56
Nucleotide sequences of small ribosomal RNA and adjacent transfer RNA genes in rat mitochondrial DNA. Gene (1981) 1.55
The serology of chronic hepatitis B infection revisited. J Clin Invest (1993) 1.54
New chimeric splice junction in adenovirus type 2-simian virus 40 hybrid viral mRNA. J Virol (1980) 1.53
Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol (1995) 1.52
Expression of hepatitis C virus NS5B protein: characterization of its RNA polymerase activity and RNA binding. Hepatology (1999) 1.52